Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Aug 09, 2022 10:29am
98 Views
Post# 34881367

RE:RE:Publication of Positive Results for PGX-Processed Alginates

RE:RE:Publication of Positive Results for PGX-Processed Alginates With cost and ease of processing the puzzle CZO has been trying to solve after talks with industry today's publication adresses that issue. Alginate is more easily loaded and with higher amounts creating even more potential efficiency.  

"...results in this article demonstrate that PGX-SA can be homogeneously and more easily loaded with even higher amount of coenzyme Q10 (CoQ10) than other previously PGX-processed biopolymers using supercritical adsorptive precipitation". News release

Marketwatch:

"According to our latest research, The global Coenzyme Q10 (CoQ10) market size is estimated to be worth USD 716.6 million in 2022 and is forecast to a readjusted size of USD 1107.8 million."
<< Previous
Bullboard Posts
Next >>